D
David Barillà
Researcher at University of Messina
Publications - 82
Citations - 687
David Barillà is an academic researcher from University of Messina. The author has contributed to research in topics: Laplace transform & Lattice (order). The author has an hindex of 13, co-authored 76 publications receiving 566 citations.
Papers
More filters
Journal ArticleDOI
Vascular access for hemodialysis: current perspectives.
Domenico Santoro,Filippo Benedetto,Patrizia Mondello,Narayana Pipitò,David Barillà,Francesco Spinelli,CarloAlberto Ricciardi,Cernaro,Michele Buemi +8 more
TL;DR: A well-functioning vascular access (VA) is a mainstay to perform an efficient hemodialysis (HD) procedure and has the lowest association with morbidity and mortality, and for this reason AVF use is strongly recommended by guidelines from different countries.
Journal Article
The sensibility and specificity of cerebral oximetry, measured by INVOS - 4100, in patients undergoing carotid endarterectomy compared with awake testing.
Francesco Stilo,Francesco Spinelli,Eugenio Martelli,Narayana Pipitò,David Barillà,G. De Caridi,F. Benedetto,D. C. Risitano,Alberto Noto,R. Messina,Antonio David +10 more
TL;DR: The results of this study suggest that the usefulness of CO in predicting cerebral ischemia is modest and the performance of the INVOS-4100 cerebral oximeter and the neurologic functions in patients undergoing CEA under LA, namely cervical plexus block is compared.
Journal ArticleDOI
The role of procalcitonin as a marker of diabetic foot ulcer infection
Mafalda Massara,Giovanni De Caridi,Raffaele Serra,David Barillà,Andrea Cutrupi,Alberto Volpe,Francesco Cutrupi,Antonino Alberti,Pietro Volpe +8 more
TL;DR: The diagnostic accuracy of PCT serum levels was evaluated in comparison with other inflammatory markers such as CRP, ESR and WBC as an indicator to make the distinction between infected diabetic foot ulcers ( IDFUs) and NIDFUs.
Journal ArticleDOI
Debate: Whether fenestrated endografts should be limited to a small number of specialized centers
TL;DR: Will widespread adoption in a larger number of smaller-volume hospitals, by less experienced surgeons, result in poor patient outcomes, or will excellent results continue with more patients benefitting from these technologic advances?
Journal ArticleDOI
Long-term Results of Endovascular Treatment of TASC C and D Aortoiliac Occlusive Disease with Expanded Polytetrafluoroethylene Stent Graft.
Umberto Bracale,Anna Maria Giribono,Domenico Spinelli,Luca del Guercio,Narayana Pipitò,Doriana Ferrara,David Barillà,Danilo Barbarisi,Graziana Derone,Filippo Benedetto +9 more
TL;DR: The results suggest that endovascular therapy of TASC C and D iliac lesions using the VIABAHN stent graft is feasible, effective, and has good, long-term patency.